Total Payments
$908.52
2022 Payments
$637.59
Companies
8
Transactions
44
Medicare Patients
237
Medicare Billing
$14,592
Payment Breakdown by Category
Food & Beverage$908.52 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $908.52 | 44 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $266.45 | 14 | $0 (2022) |
| Lilly USA, LLC | $158.13 | 8 | $0 (2022) |
| Novo Nordisk Inc | $143.72 | 7 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $134.33 | 5 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $110.87 | 5 | $0 (2022) |
| Amarin Pharma Inc. | $52.70 | 3 | $0 (2022) |
| Amgen Inc. | $23.90 | 1 | $0 (2022) |
| Merck Sharp & Dohme LLC | $18.42 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $637.59 | 31 | Bayer HealthCare Pharmaceuticals Inc. ($266.45) |
| 2021 | $270.93 | 13 | Boehringer Ingelheim Pharmaceuticals, Inc. ($82.24) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/26/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Respiratory | ||||||
| 10/25/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $34.84 | General |
| Category: Cardio-renal | ||||||
| 10/12/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Neuroscience | ||||||
| 09/16/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $32.78 | General |
| Category: Cardio-renal | ||||||
| 09/14/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Diabetes | ||||||
| 09/13/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Inflammation | ||||||
| 08/22/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: DIABETES | ||||||
| 08/11/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $5.63 | General |
| Category: Cardio-renal | ||||||
| 08/10/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $33.11 | General |
| Category: Cardio-renal | ||||||
| 08/04/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $3.53 | General |
| Category: Cardio-renal | ||||||
| 07/13/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $32.00 | General |
| Category: Cardio-renal | ||||||
| 06/29/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Diabetes | ||||||
| 06/28/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Neuroscience | ||||||
| 06/13/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Respiratory | ||||||
| 06/08/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $33.67 | General |
| Category: Cardio-renal | ||||||
| 06/02/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Diabetes | ||||||
| 05/28/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Diabetes | ||||||
| 05/25/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.36 | General |
| Category: DIABETES | ||||||
| 05/18/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Diabetes | ||||||
| 05/17/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: Cardio-renal | ||||||
| 05/16/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $0.23 | General |
| Category: Cardio-renal | ||||||
| 05/06/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $8.40 | General |
| Category: Cardio-renal | ||||||
| 04/18/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.98 | General |
| Category: Cardio-renal | ||||||
| 03/30/2022 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 224 | 229 | $80,348 | $13,938 |
| 2022 | 1 | 13 | 13 | $1,963 | $653.64 |
Total Patients
237
Total Services
242
Medicare Billing
$14,592
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 56 | $32,760 | $3,741 | 11.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $20,700 | $3,111 | 15.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 40 | 40 | $6,040 | $2,011 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 16 | $9,760 | $1,748 | 17.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $8,400 | $1,438 | 17.1% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 32 | 33 | $1,366 | $1,338 | 98.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 18 | 18 | $810.00 | $291.96 | 36.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 15 | 16 | $512.00 | $259.20 | 50.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 13 | 13 | $1,963 | $653.64 | 33.3% |
About Urmi Das
Urmi Das is a Medical healthcare provider based in Flushing, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/14/2019. The National Provider Identifier (NPI) number assigned to this provider is 1295209278.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Urmi Das has received a total of $908.52 in payments from pharmaceutical and medical device companies, with $637.59 received in 2022. These payments were reported across 44 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($908.52).
As a Medicare-enrolled provider, Das has provided services to 237 Medicare beneficiaries, totaling 242 services with total Medicare billing of $14,592. Data is available for 2 years (2022–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Flushing, NY
- Active Since 01/14/2019
- Last Updated 01/14/2019
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1295209278
Products in Payments
- Kerendia (Drug) $266.45
- JARDIANCE (Drug) $155.02
- FARXIGA (Drug) $66.10
- Rybelsus (Drug) $61.80
- Ozempic (Drug) $60.49
- TRULICITY (Drug) $55.75
- Vascepa (Drug) $52.70
- BREZTRI (Drug) $44.77
- MOUNJARO (Drug) $42.56
- EMGALITY (Drug) $39.13
- Otezla (Drug) $23.90
- RYBELSUS (Drug) $21.43
- BELSOMRA (Drug) $18.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Flushing
Wai Bong, Pa, PA
Medical — Payments: $51,861
Medical $51,861
Hector Ye, Pa, PA
Medical — Payments: $13,704
Medical $13,704
Victoria Ciano
Medical — Payments: $6,463
Medical $6,463
Ms. Michelle Li
Medical — Payments: $5,853
Medical $5,853
Yu Jin Kim
Medical — Payments: $4,500
Medical $4,500
Stephanie Lau, Pa, PA
Medical — Payments: $3,653
Medical $3,653